GNH USA

Europe — EMA

Levetiracetam Bristol Labs

GNH USA supplies Levetiracetam Bristol Labs (Levetiracetam), an anticonvulsant for partial, generalized tonic‑clonic and myoclonic seizures.

Levetiracetam

Request sourcing

1
Pack/s

What is Levetiracetam?

Levetiracetam, the active ingredient in Levetiracetam Bristol Labs, is an anticonvulsant presented as a tablet for oral use. It modulates synaptic vesicle protein SV2A, reducing neuronal excitability and helping control seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Bristol Labs as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics across global markets with adherence to EU quality standards. The company ensures consistent batch release and regulatory compliance for reliable patient care.

What is Levetiracetam used for?

Levetiracetam is used to treat seizure disorders within the antiepileptic drug class.

- Partial seizures: reduces the frequency of focal onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases occurrence of sudden muscle jerks. - Epilepsy (overall seizure control): contributes to comprehensive seizure management in patients with epilepsy.

What are the side effects of Levetiracetam?

Levetiracetam may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Fatigue - Dizziness - Somnolence - Irritability - Headache - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, skin rash) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior

What precautions apply to Levetiracetam?

When prescribing Levetiracetam, clinicians should consider several safety and handling points.

- Renal function: adjust dose in patients with impaired renal clearance. - Psychiatric symptoms: monitor for mood changes, depression or aggression. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: evaluate risk‑benefit; limited data available. - Store at ambient temperature: keep below 25 °C, protect from moisture in the original packaging.

What does Levetiracetam interact with?

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may lower levetiracetam concentrations. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may increase central nervous system depression. - Other antiepileptics (e.g., valproate): may require dose adjustment. - Antidepressants (e.g., SSRIs): monitor for behavioral changes.

Frequently asked questions

What is Levetiracetam Bristol Labs used for?+
Levetiracetam Bristol Labs is an oral antiepileptic medication indicated for the treatment of partial seizures, generalized tonic‑clonic seizures, and myoclonic seizures in patients diagnosed with epilepsy. It helps reduce the frequency and severity of seizure episodes by stabilizing neuronal activity.
How does levetiracetam work?+
Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which plays a crucial role in the regulation of neurotransmitter release. This binding modulates synaptic transmission, decreasing abnormal neuronal firing and thereby lowering the likelihood of seizure generation.
What is the usual dose of levetiracetam?+
The appropriate dose of levetiracetam is individualized and determined by the prescribing clinician based on the patient’s age, weight, renal function, seizure type, and response to therapy. Dosage regimens may vary, and adjustments are made according to clinical judgment.
Is levetiracetam safe during pregnancy or breastfeeding?+
Safety data for levetiracetam in pregnancy and lactation are limited. The drug should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss the risk‑benefit profile with the patient and consider alternative therapies when appropriate.
How do I order Levetiracetam Bristol Labs from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and any necessary import documentation.
How does levetiracetam compare with other antiepileptic drugs?+
Compared with many traditional antiepileptics, levetiracetam has a relatively simple pharmacokinetic profile, low protein binding and minimal hepatic metabolism, resulting in fewer drug‑drug interactions. It is often chosen for its broad spectrum of activity across seizure types and its ease of dosing, though individual response varies.
How should Levetiracetam Bristol Labs be stored?+
Store the tablets at ambient temperature, preferably below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or extreme temperatures.
How is Levetiracetam administered?+
Levetiracetam Bristol Labs is taken orally, usually as a whole tablet swallowed with water. It can be taken with or without food, and the dosing schedule (once, twice or multiple times daily) is set by the prescriber based on the individual treatment plan.
What are the most serious risks associated with levetiracetam?+
Serious risks include severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, as well as neuropsychiatric events like depression, aggression, or suicidal thoughts. Patients should be monitored closely for any signs of rash, mood changes, or unusual behavior, and medical attention should be sought promptly if they occur.
Who should not use levetiracetam?+
Levetiracetam should be avoided in individuals with known hypersensitivity to the drug or any of its components. Patients with severe renal impairment require careful dose adjustment, and those with uncontrolled psychiatric conditions should be evaluated thoroughly before initiation.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Levetiracetam
Route
Oral Use
Manufacturer
Bristol Laboratories Limited
Origin
EU

Related products